Apxan 5mg Tablet

Apxan 5mg Tablet contains Apixaban as its active ingredient. Apixaban is classified as a direct oral anticoagulant (DOAC) or a novel oral anticoagulant (NOAC). It is prescribed to prevent blood clots in patients at risk of stroke or systemic embolism, particularly those with atrial fibrillation, deep vein thrombosis (DVT), or pulmonary embolism (PE).

Uses:

Apxan 5mg Tablet is primarily used for the prevention of blood clots in patients with atrial fibrillation, a type of irregular heartbeat that increases the risk of stroke. It is also indicated for the prevention and treatment of DVT and PE following hip or knee replacement surgery. Apixaban works by inhibiting the activity of factor Xa, a key component in the blood clotting cascade, thereby reducing the risk of thrombus formation.

Dosage:

The dosage of Apxan 5mg Tablet is determined based on the patient’s medical condition, renal function, and other factors. It is usually taken orally, with or without food, as directed by the healthcare provider. Patients should follow the prescribed dosage regimen and adhere to regular monitoring to ensure optimal anticoagulation therapy.

Side Effects:

Common side effects associated with Apxan 5mg Tablet may include bleeding, bruising, nausea, abdominal pain, and fatigue. These side effects are usually mild and transient, but patients should seek medical attention if they experience severe bleeding, signs of anemia, or allergic reactions such as rash, itching, or difficulty breathing.

Precautions:

Before using Apxan 5mg Tablet, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. It is essential to use caution in patients with a history of bleeding disorders, liver or kidney disease, or those taking other anticoagulant medications. Apixaban may interact with certain medications, so it’s crucial to review the patient’s medication regimen to prevent potential interactions.

When Not to Use:

Apxan 5mg Tablet is contraindicated in patients with a known hypersensitivity to Apixaban or any other components of the medication. It should not be used in patients with active bleeding or a history of bleeding disorders. Additionally, this medication is not recommended for use in patients with artificial heart valves due to an increased risk of thromboembolic events.